Strohbehn, G. W., Kacew, A. J., Goldstein, D. A., Feldman, R. C. & Ratain, M. J. Nat. Biotechnol. 39, 1504–1510 (2021).

Article  CAS  PubMed  Google Scholar 

Pharmacy Benefits, V. A. Management Services. Ledipasvir/Sofosbuvir (Harvoni®) National Drug Monograph (2014).

Shlay, J. C. et al. Terry Beirn Community Programs for Clinical Research on AIDS. J. Am. Med. Assoc. 280, 1590–1595 (1998).

Article  CAS  Google Scholar 

Bosch, J. et al. BMJ 324, 699–702 (2002).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilcox, M. H. et al. N. Engl. J. Med. 376, 305–317 (2017).

Article  CAS  PubMed  Google Scholar 

Mulangu, S. et al. N. Engl. J. Med. 381, 2293–2303 (2019).

Article  CAS  PubMed  Google Scholar 

Muthas, D., Boyer, S. & Hasselgren, C. MedChemComm 4, 1058–1065 (2013).

Article  CAS  Google Scholar 

Maddipatla, M. U.S. signs $450 million contract with Regeneron for COVID-19 therapy. Reuters (2020).

Abinader, L. G. U. S. Government funding of Lilly’s LY-CoV555 antibody against COVID-19. Knowledge Ecology International (2020); https://www.keionline.org/34308

Anonymous. Regeneron enters agreement with BARDA on antibody therapy for Ebola. GEN Biotechnol. https://www.genengnews.com/topics/drug-discovery/regeneron-enters-agreement-with-barda-on-antibody-therapy-for-ebola/ (2015).

Box, G. E. P. Improving Almost Anything: Ideas and Essays rev. edn (Wiley-Interscience, 2006).

Fisher, R. A. The Design of Experiments (Oliver and Boyd, 1937).

CDER & CBER. ICH guidance Q8(R2) Pharmaceutical Development. (2020).

CDER & CBER. ICH Guidance Document Q9 Quality Risk Management. (2006).

CDER & CBER. ICH Guidance Document Q10 Pharmaceutical Quality System. (2009).

Palmer, A. C., Izar, B., Hwangbo, H. & Sorger, P. K. Clin. Cancer Res. 28, 368–377 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Jones, B. & Nachtsheim, C. J. J. Qual. Technol. 43, 1–15 (2011).

Article  Google Scholar 

Jones, B. & Nachtsheim, C. J. J. Qual. Technol. 45, 121–129 (2013).

Article  Google Scholar 

Fisher, R. A. J. Ministry Agric. 33, 503–515 (1926).

Google Scholar 

Chakraborty, B., Collins, L. M., Strecher, V. J. & Murphy, S. A. Stat. Med. 28, 2687–2708 (2009).

Article  PubMed  PubMed Central  Google Scholar 

Jaynes, J., Ding, X., Xu, H., Wong, W. K. & Ho, C.-M. Stat. Med. 32, 307–318 (2013).

Article  PubMed  Google Scholar 

Huang, H. & Chen, X. Comput. Stat. Data Anal. 157, 107150 (2021).

Article  Google Scholar 

Xiao, Q., Wang, L. & Xu, H. Stat. Med. 38, 236–246 (2019).

Article  PubMed  Google Scholar 

Abhyankar, M. M. et al. Front. Immunol. 12, 683157 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao, H. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.12.21.473715 (2022).

Taylor, P. R. et al. Linxian Nutrition Intervention Trials Study Group. Cancer Res. 54(suppl), 2029s–2031s (1994).

CAS  PubMed  Google Scholar 

Yu, L. X. et al. AAPS J. 16, 771–783 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scannell, J. W., Blanckley, A., Boldon, H. & Warrington, B. Nat. Rev. Drug Discov. 11, 191–200 (2012).

Article  CAS  PubMed  Google Scholar 

Paul, S. M. et al. Nat. Rev. Drug Discov. 9, 203–214 (2010).

Article  CAS  PubMed  Google Scholar 

Pharma Intelligence. Clinical Development Success Rates and Contributing Factors 2011–2020 (2021); https://pharmaintelligence.informa.com/resources/product-content/2021-clinical-development-success-rates